WSP Global press release ( WSPOF ): Q1 Non-GAAP EPS of $2.21. Revenues and net revenues for the quarter reached $4.55 billion and $3.71 billion, up 3.7% and 10.8%, respectively, compared to the first quarter of 2025. Backlog as at March 27, 2026 reached a new record level of $19.7 billion, up 19.0% in the twelve-month period, and representing 11.5 months of revenues. More on WSP Global Inc. WSP Global Inc. (WSP:CA) Q4 2025 Earnings Call Transcript WSP Global Inc. 2025 Q4 - Results - Earnings Call Presentation WSP prices $1.5 billion senior unsecured notes offering Historical earnings data for WSP Global Inc. Dividend scorecard for WSP Global Inc.

Key PointsAge 67 is the full retirement age for anyone born in 1960 or later.

Tom Werner/DigitalVision via Getty Images Thesis I think the buy case for Avalo Therapeutics ( AVTX ) has strengthened pretty materially now that we’ve seen the Phase 2 LOTUS readout . As you know, abdakibart delivered statistically significant and potentially differentiated efficacy in a quite difficult-to-treat indication. It also showed us a surprisingly clean safety profile and a convenient dosing regimen. Now, if we combine this with the company’s new pro forma cash position of about $450 to $470 million after their latest equity raise, I think Avalo is in a pretty decent position to advance the program into pivotal Phase 3 development. My upside-case scenario would then be that if abdakibart can replicate the efficacy and safety results in a much larger registrational study and also set itself up as a differentiated biologic in hidradenitis suppurativa, the current valuation could still look relatively modest when compared to the commercial potential of a successful late-stage inflammatory disease asset. As for the stock price, shares are trading around the $21 mark pre-market today and have run up about 66% over the last 5 days. So even though I am buy-rated on the long run potential of abdakibart, I feel there could be some stock volatility as investors take profits. Abdakibart/AVTX-009 As you know, Avalo reported this week a very interesting inflammatory-disease Phase 2 dataset. Their candidate is, of course, abdakibart/ AVTX-009 , and is tipped to target a pathway that quite a lot of researchers have believed was central to hidradenitis suppurativa ( HS ). The trouble is that historically, it’s been pretty difficult to translate that link into a clearly differentiated clinical product. You see, HS is a chronic, destructive inflammatory skin disease characterised by recurrent nodules, abscesses and sinus tracts/draining tunnels. It also comes with severe pain and scarring. Now, the existing biologics are mainly focused on TNF-α or IL-17 inhibition, and whil...

Image source: The Motley Fool. May 6, 2026, 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

AMD Q1 FY 2026: Data Center Momentum Builds as AI Deployments Scale The Futurum Group

Micron Technology (MU) Is Up 28.9% After Launching 245TB AI-Focused SSD Shipments Has The Bull Case Changed? simplywall.st

Surrozen press release ( SRZN ): Q1 Non-GAAP EPS of -$11.65. Revenue of $5M (+410.2% Y/Y). Cash and cash equivalents of $106.9M. More on Surrozen Seeking Alpha’s Quant Rating on Surrozen Historical earnings data for Surrozen Financial information for Surrozen

Sundry Photography/iStock Editorial via Getty Images Shares of Alpha and Omega Semiconductor ( AOSL ) fell around 20% on Thursday after its fiscal fourth-quarter revenue outlook missed estimates. Outlook "While visibility into second half of calendar 2026 remains limited, particularly given the uncertainty around memory pricing and availability, we expect modest revenue growth for the calendar year. Importantly, our targeted R&D investments and continued expansion into higher-performance applications position AOS well for accelerating growth as new programs ramp in 2027 and beyond," said CEO Stephen Chang. For the fiscal fourth quarter the company expects revenue to be about $168M, plus or minus $10M, compared to a consensus revenue estimate of $171.13M. Alpha and Omega expects GAAP gross margin to be 22.3%, plus or minus 1%, and non-GAAP gross margin to be 23.0%, plus or minus 1%, for the fiscal fourth quarter. Q3 Metrics For the fiscal third quarter ended March 31, the company's revenue fell 0.5% year-over-year to $163.8M. Non-GAAP net loss per share was $0.28, compared to a net loss per share of $0.10 in the same period a year ago. However, both the top and bottom lines beat estimates. "Our March quarter results were slightly above the midpoint of our guidance, supported by strength in Advanced Computing, including AI, servers and graphics, as well as continued momentum with our Tier One U.S. smartphone customer. While seasonal softness in PCs and ongoing weakness in certain consumer applications persisted, we are encouraged by the growing contribution from higher-performance applications and improving product mix," said Chang. "We believe the December and March quarters marked a near-term bottom for both revenue and margins, and we are seeing early signs of momentum building as we move into the June quarter, driven by a richer product mix and stronger contributions from higher-performance applications." The company noted that it closed the quarter with $190.3M o...

格隆汇5月7日｜纳斯达克中国金龙指数跌超1%，万国数据跌4.73%，Tims中国跌4.21%，金山云跌4.00%，再鼎医药跌3.76%，嘉楠科技跌3.68%。

The brokerage sector is producing one of the widest divergences of 2026 so far. Robinhood Markets (NASDAQ:HOOD) is down 30% year to date (YTD), while Interactive Brokers Group (NASDAQ:IBKR) is up 36% YTD. That roughly 65-point spread heading into mid-May tells a revealing story about customer mix and revenue durability. HOOD stock closed at $79.05 ... Robinhood Is Down 30% in 2026 While Interactive Brokers Is Up 35%: Here’s Why

Bloomberg's Redd Brown discusses the recent earnings reports from McDonald's, Shake Shack and Whirlpool. McDonald's reported solid earnings but noted a meaningful decline in consumer sentiment in the second quarter. Shake Shack faced weaker earnings as it absorbed higher costs without passing them fully to customers. Whirlpool also reported concerns, citing a recession-level decline in consumer sentiment that is beginning to affect big-ticket purchases like appliances. (Source: Bloomberg)

CDC says monitoring US travelers on cruise ship after hantavirus outbreak Reuters

Poland’s central bank Governor Adam Glapinski said the likelihood of interest rate increases has grown over the past month although a hike is not a forgone conclusion for policymakers. Glapinski’s Monetary Policy Council left its benchmark unchanged for a second straight month in May, citing a tense geopolitical situation in the Middle East that’s caused uncertainties for the Polish economy. “Rate hikes are likely but they may not occur,” Glapinski told a news conference on Thursday. On the other hand, “rate cuts are very unlikely.” The comments mark a further tilt toward hawkish rhetoric by Polish policymakers, who cut interest rates in the first days of the Iran war and have since switched to a wait-and-see stance. The benchmark rate stands at 3.75%, down 200 basis points over the last 12 months. Poland’s headline inflation jumped to 3.2% in April, near the 3.5% upper limit of the central bank’s target range. Adding to the inflation risks, the April readout of S&P Global manufacturing purchasing managers’ index for Poland showed input prices increasing at their fastest pace since 2022.

Rackspace stock rallies on AMD enterprise AI cloud partnership (RXT:NASDAQ) Seeking Alpha

格隆汇5月7日｜原油期货延续了前一交易日的跌势，背景是市场表现出一定的乐观情绪，认为美伊之间达成协议的最新努力可能会取得成果，并促使霍尔木兹海峡重新开放。XS.com的Samer Hasn在一份报告中表示：“目前的这些外交努力能否成功仍有待观察。”“与此同时，该海峡仍然关闭，石油供应中断，库存正在耗尽。“西得州中质油下跌4.9%，报每桶90.45美元；布伦特原油下跌4.5%，报每桶96.74美元。

Pharming press release ( PHAR ): Q1 GAAP EPS of $0.00 in-line. Revenue of $72.4M (-8.5% Y/Y) misses by $19.67M . Strong Joenja growth, total revenues of US$72.4M, -8% on RUCONEST inventory drawdowns and non-U.S. exit. Positive operating cash flow of US$2.0M, reflecting continued strong cost management and financial discipline. Cash and marketable securities US$171.8M, down US$9.3M vs FY25 due to -US$12.3M for DSP lease termination. 2026 financial guidance and long-term capital outlook Revenue and operating expenses (in constant currency): FY 2026 Guidance Total Revenues Operating Expenses US$405 - 425 million Notes • 8 - 13% growth, with quarterly fluctuations • +US$60M R&D to advance pipeline US$330 - 335 million •-US$9M G&A structural cost reductions (as announced in October 2025) More on Pharming Pharming Group N.V. 2026 Q1 - Results - Earnings Call Presentation Pharming Group N.V. (PHAR) Presents at 25th Annual Needham Virtual Healthcare Conference - Slideshow Pharming Group N.V. 2025 Q4 - Results - Earnings Call Presentation Pharming granted EU backing for rare immunodeficiency therapy Pharming outlines $405M–$425M 2026 revenue target as Joenja and RUCONEST drive growth

Rosenblatt resets Palantir stock price target after earnings thestreet.com

The Nasdaq Composite (^IXIC) etched a fresh all-time high and shows little sign of slowing down, with the tech-heavy benchmark up roughly 14% over the past month alone. Semiconductors have carried much of the load: the Philadelphia Semiconductor Index (^SOX) has surged around 60% year-to-date. Right now the stars are aligning: cooling oil prices, a ... Stars Align for Nasdaq Composite as Chip Stocks Roar and Oil Pulls Back

Bet_Noire/iStock via Getty Images Silver has crossed $80, and for the miners, the implications are significant. The metal's ascent, driven by a combination of industrial demand from solar panels and electric vehicles, safe-haven buying, and a weakening U.S. dollar, is translating into outsized leverage for silver producers. Below is a list of the top holdings from the Global X Silver Miners ETF, arranged by their year-to-date performance. The list includes stocks from the silver mining sector and provides market capitalization data along with Quant ratings as screening criteria. The list is topped by SSR Mining Inc. ( SSRM ), with a YTD performance of 48.81%. First Majestic Silver Corp. ( AG ) and Compañía de Minas Buenaventura S.A.A. ( BVN ) follow with strong performances of 27.13% and 22.35%, respectively. Wheaton Precious Metals Corp. ( WPM ) and Pan American Silver Corp. ( PAAS ) are also among the significant holdings, with YTD gains of 14.51% and 9.23%. The list extends to stocks with lower or negative YTD performance, including Industrias Peñoles, S.A.B. de C.V. ( IPOAF ) at -3.51% and Hecla Mining Company ( HL ) at -5.42%. Here is the list: SSR Mining Inc. ( SSRM ), YTD perf: 48.81%, Quant Rating: Hold 3.36 First Majestic Silver Corp. ( AG ), YTD perf: 27.13%, Quant Rating: Hold 3.46 Compañía de Minas Buenaventura S.A.A. ( BVN ), YTD perf: 22.35%, Quant Rating: Buy 4.49 Wheaton Precious Metals Corp. ( WPM ), YTD perf: 14.51%, Quant Rating: Hold 3.38 Pan American Silver Corp. ( PAAS ), YTD perf: 9.23%, Quant Rating: Strong Buy 4.58 Fresnillo plc ( FNLPF ), YTD perf: 5.56%, Quant Rating: Not Covered Coeur Mining, Inc. ( CDE ), YTD perf: 5.16%, Quant Rating: Buy 4.12 Industrias Peñoles, S.A.B. de C.V. ( IPOAF ), YTD perf: -3.51%, Quant Rating: Not Covered Hecla Mining Company ( HL ), YTD perf: -5.42%, Quant Rating: Hold 3.16 Silver and Silver Mining ETFs : ( SLV ), ( SIVR ), ( AGQ ), ( ZSL ), ( PSLV ), ( SIL ), ( SILJ ), and ( SLVP ) More on iShares Silver Tru...

2026 will be a make-or-break year as the company prepares to launch its first mass-market Specs, Snap (NASDAQ:SNAP) CEO Evan Spiegel recently said, calling it a "crucible moment" for consumer augmented reality glasses. The glasses are designed to keep users...

matejmo/iStock via Getty Images Twist Bioscience ( TWST ) delivered strong results in the second quarter, driven by AI-enabled drug discovery customers. While NGS growth was modest, this was largely the result of a large customer that is transitioning from clinical trials to commercialization. As a result, NGS growth is expected to rebound as the year progresses. In addition, cancer screening and MRD monitoring remain large opportunities that are likely to accelerate growth over the next 1-2 years, and Twist's product portfolio continues to expand. I previously suggested that liquid biopsy and AI tailwinds would drive Twist's share price higher. The stock is up around 20% since then and Twist's valuation is now far less attractive than it was in late 2025, meaning further near-term upside is likely limited. Despite this, I believe that any material share price weakness is an opportunity to accumulate. Twist Bioscience Business Updates While Twist's business is gaining momentum at the moment, this is largely occurring in a weak demand environment. For example, the academic end market is still under funding pressure and Twist is extending its express gene discount to gain share amongst these customers . Large parts of the biopharma market also remain soft, although AI driven growth is becoming more broad-based. Twist's growth in this area is supported by efforts to move up the customer value chain from oligos towards proteins, data and services. Amazon Web Services recently announced Twist as a wet lab partner for its AI-powered drug discovery application (Amazon Bio Discovery), a service that helps customers to use AI to design and optimize antibodies. Twist has also strengthened its antibody discovery service by licensing the B-Body platform from Invenra. The agreement involves a 5 million USD upfront payment and 15 million USD of Twist's stock. Twist also paid around 14 million USD for a 6% stake in Invenra. Bispecifics are difficult to make and Invenra's platform ...

Penn Capital Management Company disclosed in a May 6, 2026, SEC filing that it sold 1,130,234 shares of The RealReal (NASDAQ:REAL) , an estimated $14.30 million transaction based on quarterly average pricing. An SEC filing dated May 6, 2026, shows Penn Capital Management Company reduced its position in The RealReal by 1,130,234 shares during the first quarter. The estimated transaction value is $14.30 million, based on the average closing price in the period. The fund’s stake at quarter-end was 206,440 shares, now valued at $1.87 million. The net position change, reflecting both trading and price movement, was a decrease of $19.24 million. The RealReal is a U.S.-based online marketplace specializing in consigned luxury goods, connecting consignors with buyers of high-end products. Continue reading

Element Fleet Management press release ( ELEEF ): Non-GAAP EPS of $0.30. Revenue of $323.5M (+17.3% Y/Y). More on Element Fleet Management Corp. Element Fleet Management Corp. 2026 Q1 - Results - Earnings Call Presentation Element Fleet Management Corp. (EFN:CA) Q4 2025 Earnings Call Transcript Element Fleet Management Corp. 2025 Q4 - Results - Earnings Call Presentation Historical earnings data for Element Fleet Management Corp. Dividend scorecard for Element Fleet Management Corp.

Rush-released in the same year as Prince of Thieves blockbuster, this gritty British movie battled winter weather and chronic illness – and it still holds up Thirty-five years ago, two films about the legend of Robin Hood – stealer from the rich, giver to the poor – met and duelled in cinemas; we all know who won, Kevin Costner’s big-budget blockbuster, Robin Hood: Prince of Thieves. But what about the other one? It was titled simply Robin Hood, directed by John Irvin and starring Patrick Bergin in the title role alongside a pre-Pulp Fiction Uma Thurman as Maid Marian. “It was very much a stand-alone film with the aim of giving Kevin Costner’s version a good kicking if we could,” says Irvin, now 85. “The studio wanted to go immediately because they wanted to pre-empt the Costner.” Continue reading...

Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls

格隆汇5月7日｜德国工商大会主席Peter Adrian周四猛烈批评德国总理默茨改革表现不佳，并称其执政联盟“功能失调且缺乏可靠性”。Adrian周四在一场商业会议上表示：“德国商界目前认为联邦政府已经功能失调。”默茨本人也出席了此次会议。“在许多领域，我们的国家已经变得过于复杂、过于昂贵且效率过低，”Adrian补充说，越来越多企业正在将投资转移至其他地区，因为在那些地方决策制定速度更快，也更加务实。默茨于一年前上任时承诺，将重振德国这一欧洲最大经济体，恢复德国在欧盟内部的领导地位。但如今这位处境艰难的总理在所有这些方面都面临困境。Adrian表示：“恰恰是在危机时期，弱点和失误会暴露得尤其明显。”他指出，这包括“失控的官僚体系、错误的气候与能源政策、过高的劳动力和社会保障成本，以及过高的企业税负”。

他表示，“我们的目标是扩大与中国的贸易，并吸引更多中国投资到英国” 【财新网】 “正如我们首相（即英国首相斯塔默）今年早些时候所说，当今世界没有一项变革，比中国的崛起更具重要性。”伦敦时间5月7日，英国驻华大使魏磊（Peter Wilson）在第二届“财新伦敦大西洋对话”上说。 通过线上连线发表主旨演讲的魏磊补充称，“在此背景下，我们希望与中国这一对我们至关重要的国家建立更强、更全面、也更具长期性的关系。我亦认为，英国同样是一个对中国至关重要的国家。” 这是在首届“财新伦敦大西洋对话”于2025年成功举行之后的第二届活动。本届论坛以“从太平洋到大西洋：顺应演变中的世界格局”为主题，在英国伦敦金丝雀码头举行。

Moonshot's annualized recurring revenue topped $200 million in April, driven by rapid growth in paid subscriptions and API usage.